These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11895068)

  • 1. Thalidomide use in pediatric patients.
    Bessmertny O; Pham T
    Ann Pharmacother; 2002 Mar; 36(3):521-5. PubMed ID: 11895068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of thalidomide use in the pediatric population.
    Yang CS; Kim C; Antaya RJ
    J Am Acad Dermatol; 2015 Apr; 72(4):703-11. PubMed ID: 25617013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide: a re-look.
    Grover JK; Vats V; Gopalakrishna R; Ramam M
    Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide: dermatological indications, mechanisms of action and side-effects.
    Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
    Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide: current and potential clinical applications.
    Calabrese L; Fleischer AB
    Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide: new preparation. For well-defined indications.
    Prescrire Int; 1998 Oct; 7(37):131-4. PubMed ID: 10848043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al.
    Gompel A; Frances C; Piette JC; Blanc AS; Cordoliani F; Piette AM
    Arthritis Rheum; 1999 Oct; 42(10):2259-60. PubMed ID: 10524707
    [No Abstract]   [Full Text] [Related]  

  • 8. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis.
    Revuz J; Guillaume JC; Janier M; Hans P; Marchand C; Souteyrand P; Bonnetblanc JM; Claudy A; Dallac S; Klene C
    Arch Dermatol; 1990 Jul; 126(7):923-7. PubMed ID: 2193629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
    Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
    N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient secondary amenorrhea in women treated by thalidomide.
    Frances C; El Khoury S; Gompel A; Bécherel PA; Chosidow O; Piette JC
    Eur J Dermatol; 2002; 12(1):63-5. PubMed ID: 11809598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide: a review of approved and investigational uses.
    Matthews SJ; McCoy C
    Clin Ther; 2003 Feb; 25(2):342-95. PubMed ID: 12749503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide: an antineoplastic agent.
    Amato RJ
    Curr Oncol Rep; 2002 Jan; 4(1):56-62. PubMed ID: 11734114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide in leprosy and some dermatological conditions--a review.
    Parikh DA; Maniar JK; Ganapati R
    Indian J Lepr; 1985; 57(4):862-7. PubMed ID: 3915010
    [No Abstract]   [Full Text] [Related]  

  • 14. Thalidomide for the treatment of chronic graft-versus-host disease.
    Vogelsang GB; Farmer ER; Hess AD; Altamonte V; Beschorner WE; Jabs DA; Corio RL; Levin LS; Colvin OM; Wingard JR
    N Engl J Med; 1992 Apr; 326(16):1055-8. PubMed ID: 1549151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential novel uses of thalidomide: focus on palliative care.
    Peuckmann V; Fisch M; Bruera E
    Drugs; 2000 Aug; 60(2):273-92. PubMed ID: 10983733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature.
    Mehta P; Kedar A; Graham-Pole J; Skoda-Smith S; Wingard JR
    Pediatrics; 1999 Apr; 103(4):e44. PubMed ID: 10103336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thalidomide--a dreaded drug with new indications].
    Waage A; Seidel C
    Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2954-7. PubMed ID: 11715779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
    Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
    Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation.
    Cole CH; Rogers PC; Pritchard S; Phillips G; Chan KW
    Bone Marrow Transplant; 1994 Dec; 14(6):937-42. PubMed ID: 7711671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thalidomide in the treatment of aphthosis and Behçet's disease. 4 years' experience].
    Torras H; Lecha M; Mascaró/ JM
    Med Cutan Ibero Lat Am; 1982; 10(2):103-112. PubMed ID: 6759802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.